News Focus
News Focus
icon url

manibiotech

10/05/24 2:57 PM

#724195 RE: Investor082 #724194

Well this is from past annual report : kind of tells the confidence in ROI :
Anyway this is past now , but i sure think things could have been done differently to gain the confidence of broader market over the years .


“Related Parties Loans

Linda F. Powers - Demand Loans

Between February 2018 and April 2018, the Company’s Chief Executive Officer, Linda Powers, loaned the Company aggregate funding of $5.4 million pursuant to convertible Notes. The Notes were 15-day demand notes, for loans provided as short-term bridge loans. However, repayment was not completed for nearly 1-1/2 years.

During the year ended December 31, 2019, the Company repaid the $5.4 million principal and approximately $0.8 million interest.

Loan from Advent BioServices

Advent BioServices provided a short-term loan to the Company in the amount of $65,000 on September 26, 2018. The loan bore interest at 10% per annum, and is payable upon demand, with 7 days’ prior written notice to the Company.

During the year ended December 31, 2020, the Company made full repayment of $73,000 to Advent, including all outstanding interest.

Loan from Leslie Goldman

During the year ended December 31, 2020, the Company's Senior Vice President, General Counsel, Leslie Goldman, loaned the Company $315,000 pursuant to various convertible notes (the “Notes”). The Notes bore interest rate at 10% per annum and fifty percent warrant coverage, and are repayable upon 15 days' notice from the holder. The Notes were convertible, in whole or in part, into stock together with warrants.”
icon url

SkyLimit2022

10/05/24 3:02 PM

#724198 RE: Investor082 #724194

Investor082,

You’re posting nonsense and distorting reality. BP is involved as their FDA approved products are in clinical trials with TWO distinct DC technologies owned by NWBO. Those combo trials have only recently reached PII and their data are beginning to emerge now.

It’s better to stick with verifiable facts and reliable sources. We don’t want to hear defamatory baseless rumors.

Specifically, we want to hear what the clinical data say, what independent peer-reviewers say about those data, and what government regulators have to say.

Speculation on a message board is fine of course, but the discussion should be based on factual information, verifiable evidence, and credible full-context sources.

https://nwbio.com/audio-of-nwbio-2023-annual-shareholders-meeting/


https://www.nature.com/articles/s41467-024-48073-y


https://thejns.org/caselessons/downloadpdf/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.pdf


https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175185151

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927
Bullish
Bullish